1
|
Jin SS, Yu B, Yan SC, Sun W, Cui XM, Zhou X, Yang LQ, Na LX, Guo Y, Bian Z, Li LM, Chen ZM. [Effect of famine exposure on the risk of chronic disease in later life among population in Harbin]. Zhonghua Liu Xing Bing Xue Za Zhi 2018; 39:1314-1318. [PMID: 30453429 DOI: 10.3760/cma.j.issn.0254-6450.2018.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the relations between famine exposure and the risk of chronic diseases as diabetes mellitus, obesity, hypertension, coronary heart disease and stroke in the population of Harbin. Methods: Our data was collected from the baseline survey-the China Kadoorie Biobank project (CKB) in Harbin. Retrospective cohort study design was used. Related risks on chronic diseases including diabetes mellitus, obesity, hypertension, coronary heart disease and stroke, were compared among the famine exposed or non-exposed people, respectively by logistic analysis method. Results: After adjusted for factors as age, sex, physical activity, smoking, alcohol intake, diet, family history of diseases, it appeared that the factor 'famine exposure' had increased the risks of diseases as obesity (OR=1.204, 95%CI: 1.104-1.313, P<0.01), hypertension (OR=1.315, 95%CI: 1.210-1.429, P<0.01) and coronary heart disease (OR=1.495, 95%CI: 1.369-1.632, P<0.01). The lower the age of population being exposed to famine, the greater the risk of the development of all kinds of chronic diseases. Conclusions: Famine exposure appeared a risk factor for obesity, hypertension, and coronary heart disease. It is of great significance to ensure the life-long nutrition of the people, especially in the early and adolescent stages, to prevent obesity, hypertension, and coronary heart disease in their later lives.
Collapse
Affiliation(s)
- S S Jin
- Harbin Medical University, Harbin 150081, China; Nangang District, Harbin Center for Disease Control and Prevention, Harbin 150056, China
| | - B Yu
- Nangang District, Harbin Center for Disease Control and Prevention, Harbin 150056, China
| | - S C Yan
- Heilongjiang Center for Disease Control, Harbin 150036, China
| | - W Sun
- Heilongjiang Center for Disease Control, Harbin 150036, China
| | - X M Cui
- Heilongjiang Center for Disease Control, Harbin 150036, China
| | - X Zhou
- Heilongjiang Center for Disease Control, Harbin 150036, China
| | - L Q Yang
- Nangang District, Harbin Center for Disease Control and Prevention, Harbin 150056, China
| | - L X Na
- Harbin Medical University, Harbin 150081, China
| | - Y Guo
- Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Z Bian
- Chinese Academy of Medical Sciences, Beijing 100730, China
| | - L M Li
- Peking University School of Public Health, Beijing 100191, China
| | - Z M Chen
- Nuffield Department of Population Health, Center for Clinical and Epidemiological Studies, University of Oxford, Oxford OX3 7LF, UK
| |
Collapse
|
2
|
Qi N, Jung K, Wang M, Na LX, Yang ZJ, Zhang LR, Guse AH, Zhang LH. A novel membrane-permeant cADPR antagonist modified in the pyrophosphate bridge. Chem Commun (Camb) 2011; 47:9462-4. [PMID: 21785757 DOI: 10.1039/c1cc13062e] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A concise method for the formation of cyclopyrophosphate of cIDPRE as well as sulfur and selenium-substituted pyrophosphate cIDPRE analogues (P(1)(S)-cIDPRE, P(1)(Se)-cIDPRE, P(2)(S)-cIDPRE and P(2)(Se)-cIDPRE) was reported and one of the P(S)-diastereoisomers, P(1)(S)-cIDPRE-1, is a novel membrane-permeant cADPR antagonist.
Collapse
Affiliation(s)
- N Qi
- State Key Laboratory of Natural & Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Yu AM, Song RL, Yu Z, Chen YP, Wang FZ, Na LX, Xie GL, Yang MJ. Detection of human cytomegalovirus antigen and DNA in lymph nodes and peripheral blood mononuclear cells of patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Arch Pathol Lab Med 1992; 116:490-4. [PMID: 1316112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The cause of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) remains unknown. It is characterized by acute onset, severe constitutional symptoms, cervical or generalized lymphadenopathy, lymphopenia, and polyclonal hypergammaglobulinemia, all of which are highly suggestive of a viral origin. Using immunohistochemical methods, employing murine monoclonal antibody as the primary antibody, we detected human cytomegalovirus antigen in the lymph nodes of eight of 11 patients with AILD. Cytomegalovirus DNA was also detected in the peripheral blood mononuclear cells by DNA dot hybridization in all five of the patients with AILD who were tested using this technique. None of the lymph nodes from the 11 patients stained positive for the rubella virus antigen. Based on the above evidence and the similarity of the immunologic abnormalities found in both AILD and cytomegalovirus infection, the possible role of cytomegalovirus as one of the causative agents for AILD is proposed.
Collapse
Affiliation(s)
- A M Yu
- Department of Pathology, China Medical University, Liaoning
| | | | | | | | | | | | | | | |
Collapse
|